Titan Biotech

62
Hold
  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE150C01029
  • NSEID:
  • BSEID: 524717
INR
398.50
10.85 (2.8%)
BSENSE

Oct 09

BSE+NSE Vol: 21.66 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
206.00
156.00
164.00
143.00
123.00
142.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
206.00
156.00
164.00
143.00
123.00
142.00
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
-2.00
-5.00
0.00
0.00
-2.00
Raw Materials Consumed
99.00
75.00
80.00
70.00
59.00
67.00
Power & Fuel Cost
12.00
9.00
9.00
8.00
6.00
4.00
Employee Cost
32.00
26.00
23.00
18.00
14.00
14.00
Operating Expenses
9.00
7.00
8.00
6.00
5.00
4.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
9.00
8.00
6.00
6.00
4.00
6.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
1.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
167.00
131.00
129.00
114.00
92.00
96.00
Operating Profit (PBDIT) excl Other Income
38.00
25.00
34.00
29.00
31.00
46.00
Other Income
5.00
3.00
1.00
1.00
0.00
0.00
Operating Profit (PBDIT)
44.00
29.00
36.00
31.00
32.00
46.00
Interest
0.00
0.00
1.00
0.00
0.00
1.00
Profit before Depriciation and Tax
43.00
28.00
34.00
30.00
31.00
45.00
Depreciation
4.00
4.00
3.00
2.00
2.00
2.00
Profit Before Taxation & Exceptional Items
38.00
24.00
31.00
28.00
28.00
43.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
38.00
24.00
31.00
28.00
28.00
42.00
Provision for Tax
10.00
6.00
7.00
7.00
7.00
11.00
Profit After Tax
27.00
18.00
23.00
21.00
21.00
31.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
136.00
116.00
92.00
69.00
48.00
22.00
Profit Available for appropriations
165.00
137.00
117.00
94.00
70.00
52.00
Appropriations
165.00
137.00
117.00
94.00
70.00
52.00
Equity Dividend (%)
25.00%
20.00%
20.00%
18.00%
15.00%
15.00%
Earnings Per Share
7.23
26.06
30.07
30.06
26.24
36.71
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 31.79% vs -4.65% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 51.82% vs -25.83% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 13.98% vs -31.47% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 50.22% vs -22.79% in Mar 2025

Compare Profit and Loss Results of Titan Biotech
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
206.00
0
206.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
206.00
0
206.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
0
-2.00
0%
Raw Materials Consumed
99.00
0
99.00
0%
Power & Fuel Cost
12.00
0
12.00
0%
Employee Cost
32.00
0
32.00
0%
Operating Expenses
9.00
0
9.00
0%
General and Administration Expenses
-1.00
0
-1.00
0%
Selling and Distribution Expenses
9.00
0
9.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
1.00
0
1.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
167.00
0
167.00
0%
Operating Profit (PBDIT) excl Other Income
38.00
0.00
38.00
0%
Other Income
5.00
0
5.00
0%
Operating Profit (PBDIT)
44.00
0
44.00
0%
Interest
0.00
0
0.00
0%
Profit before Depriciation and Tax
43.00
0
43.00
0%
Depreciation
4.00
0
4.00
0%
Profit Before Taxation & Exceptional Items
38.00
0
38.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
38.00
0
38.00
0%
Provision for Tax
10.00
0
10.00
0%
Profit After Tax
27.00
0
27.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
136.00
0
136.00
0%
Profit Available for appropriations
165.00
0
165.00
0%
Appropriations
165.00
0
165.00
0%
Equity Dividend (%)
25%
0%
25.00
Earnings Per Share
7.23
0
7.23
0%
Profit And Loss - Net Sales
Net Sales 206.19 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 31.79% vs -4.65% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 38.60 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 51.82% vs -25.83% in Mar 2025

Profit And Loss - Interest
Interest 0.91 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 13.98% vs -31.47% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 27.45 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 50.22% vs -22.79% in Mar 2025